Market Cap $60.92M
!
Corporate Spotlight
Compumedics is at an inflection point—scaling FDA-cleared platforms (Somfit®), commercializing world-class neuroimaging (OrionMEG®), and building recurring SaaS revenues. Combined with strong FY25 execution and a Board focused on capital markets, CMP is poised to unlock both operational growth and a
View the full Corporate Spotlight
COMPUMEDICS EYES $70M FY26 TARGET AHEAD OF US PIVO
Last update - 16.00pm 16/03/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 28.0¢ | 13357 | 0 | 30.5¢ | 33753 | |
Directors & Senior Management
| Mr. Christopher R. Barys | Non-Executive Director |
| Dr. David Burton | Founder, Executive Chairman & CEO |
| Mr. David Francis Lawson | CFO, Company Secretary & Executive Director |
| Dr. Kerry Trent Hubick | Legal Counsel and Trademark, Patent & General Legal Attorney |
| Mr. Rodney James North | Non-Executive Director |
| Mr. Warwick Freeman | Chief Technology Officer |
Data source: ADVFN